WG
Winton Group Portfolio holdings
AUM
$1.96B
1-Year Return
30.2%
This Quarter Return
+2.64%
1 Year Return
+30.2%
3 Year Return
+112.22%
5 Year Return
+251.53%
10 Year Return
+656.5%
AUM
$1.91B
AUM Growth
+$255M
(+15%)
Cap. Flow
+$257M
Cap. Flow
% of AUM
13.49%
Top 10 Holdings %
Top 10 Hldgs %
16.11%
Holding
1,209
New
220
Increased
457
Reduced
252
Closed
273
Top Buys
| 1 |
Technology Select Sector SPDR Fund
XLK
|
$38.9M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
$26.3M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$17M |
| 4 |
Amazon
AMZN
|
$16.9M |
| 5 |
Union Pacific
UNP
|
$16.3M |
Top Sells
| 1 |
iShares MBS ETF
MBB
|
$22.6M |
| 2 |
CF Industries
CF
|
$20.3M |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
$18.7M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
$15M |
| 5 |
Raymond James Financial
RJF
|
$14.6M |
Sector Composition
| 1 | Financials | 20.14% |
| 2 | Consumer Discretionary | 13.72% |
| 3 | Industrials | 10.8% |
| 4 | Healthcare | 9.83% |
| 5 | Technology | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Axalta
AXTA
$6.76B
| – | – |
-9,156
| Closed | -$303K |
|
1102
Baxter International
BAX
$12.1B
| – | – |
-13,346
| Closed | -$1.15M |
|
1103
BridgeBio Pharma
BBIO
$9.91B
| – | – |
-13,253
| Closed | -$221K |
|
1104
Boise Cascade
BCC
$3.26B
| – | – |
-2,832
| Closed | -$202K |
|
|
BDN
1105
Brandywine Realty Trust
BDN
$749M
| – | – |
-13,506
| Closed | -$181K |
|
1106
BGSF Inc
BGSF
$68.6M
| – | – |
-11,080
| Closed | -$159K |
|
1107
Benchmark Electronics
BHE
$1.45B
| – | – |
-9,267
| Closed | -$251K |
|
1108
Biogen
BIIB
$20.5B
| – | – |
-1,444
| Closed | -$346K |
|
1109
Booking.com
BKNG
$181B
| – | – |
-559
| Closed | -$1.34M |
|
1110
Bumble
BMBL
$672M
| – | – |
-9,181
| Closed | -$311K |
|
1111
DMC Global
BOOM
$143M
| – | – |
-13,682
| Closed | -$542K |
|
1112
Box
BOX
$4.74B
| – | – |
-24,895
| Closed | -$652K |
|
|
BPMC
1113
DELISTED
Blueprint Medicines
BPMC
| – | – |
-18,951
| Closed | -$2.03M |
|
1114
Bruker
BRKR
$4.52B
| – | – |
-13,015
| Closed | -$1.09M |
|
1115
Braze
BRZE
$2.92B
| – | – |
-2,664
| Closed | -$206K |
|
1116
BioXcel Therapeutics
BTAI
$52M
| – | – |
-766
| Closed | -$249K |
|
1117
CBRE Group
CBRE
$48.1B
| – | – |
-3,382
| Closed | -$367K |
|
1118
Crown Castle
CCI
$41.6B
| – | – |
-7,806
| Closed | -$1.63M |
|
1119
CareDx
CDNA
$697M
| – | – |
-8,474
| Closed | -$385K |
|
1120
Celanese
CE
$5.08B
| – | – |
-4,413
| Closed | -$742K |
|
1121
Dover
DOV
$24.5B
| – | – |
-2,384
| Closed | -$433K |
|
1122
Church & Dwight Co
CHD
$23.2B
| – | – |
-51,293
| Closed | -$5.26M |
|
|
CHMI
1123
Cherry Hill Mortgage Investment Corp
CHMI
$105M
| – | – |
-14,409
| Closed | -$119K |
|
1124
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| – | – |
-27,761
| Closed | -$443K |
|
1125
Chewy
CHWY
$17B
| – | – |
-17,362
| Closed | -$1.02M |
|